# PWS Outcomes Assessment Study

> **NCT04102839** · — · COMPLETED · sponsor: **Soleno Therapeutics, Inc.** · enrollment: 59 (actual)

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **OTHER:** Interview

## Key facts

- **NCT ID:** NCT04102839
- **Lead sponsor:** Soleno Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-15
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2024-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102839, "PWS Outcomes Assessment Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04102839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*